Skip to main content

and
  1. Article

    Open Access

    Metabolic models predict bacterial passengers in colorectal cancer

    Colorectal cancer (CRC) is a complex multifactorial disease. Increasing evidence suggests that the microbiome is involved in different stages of CRC initiation and progression. Beyond specific pro-oncogenic me...

    Daniel R. Garza, Rahwa Taddese, Jakob Wirbel, Georg Zeller in Cancer & Metabolism (2020)

  2. Article

    Open Access

    RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres

    Treatment options for patients with metastatic colorectal cancer (mCRC) include anti-epithelial growth factor therapies, which, in Europe, are indicated in patients with RAS wild-type tumours only and require pri...

    Annemarie Boleij, Véronique Tack, Aliki Taylor, George Kafatos in BMC Cancer (2016)

  3. No Access

    Chapter

    Streptococcus bovis and Colorectal Cancer

    The most salient feature of Streptococcus bovis (SB) is its clinical association with malignancy of the colon and rectum. The relationship between SB and colorectal cancer (CRC) was already recognized in the 1950...

    Harold Tjalsma, Annemarie Boleij, Ikuko Kato in Bacteria and Cancer (2012)

  4. No Access

    Article

    Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin

    Systemic chemotherapy has limited success in treating liver metastasis of colorectal cancer. Alternative approaches such as hepatic arterial infusion or trans arterial chemoembolisation aim to deliver the chem...

    Ergül Eyol, Annemarie Boleij, Rachel R. Taylor in Clinical & Experimental Metastasis (2008)